MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,085
Unique beneficiaries
—
Total services
7,017
Distinct HCPCS
12
Medicare payment
$189K
PRESCRIBING · PART D · 2024
Total Rx claims
3,949
Beneficiaries
—
Total drug cost
$2.6M
Distinct drugs
42
Brand share
59.1%
Top prescribed drugs
Levothyroxine Sodium421 claims
Dulaglutide387 claims
Semaglutide331 claims
Metformin Hcl260 claims
Glipizide232 claims
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
75.9
Cost
74.6
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.42%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE